RAPT Therapeutics, Inc. (RAPT) earnings
RAPT earnings moved a median of +0.42% by the close. Quarterly and annual RAPT reports and results, each read against the price at its own news timestamp. Back to the RAPT overview →
16 measured RAPT earnings events.
Where these RAPT earnings landedvs 16 measured RAPT earnings reactions
| Middle 50% of RAPT earnings reactions | -3.93% to +2.72% |
|---|---|
| Median reaction (to close) | +0.42% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 RAPT earnings events with a measured close landed between -3.93% and +2.72%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q RAPT Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.02% | +2.72% | |
| RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights | Press release | +0.02% | +2.72% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.37% | +1.08% | |
| RAPT Therapeutics Reports Second Quarter 2025 Financial Results | Press release | -2.37% | +1.08% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.06% | -4.69% | |
| RAPT Therapeutics Reports First Quarter 2025 Financial Results | Press release | +0.06% | -4.69% | |
| Form 10-K RAPT Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.83% | +2.75% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.25% | -0.03% | |
| RAPT Therapeutics Reports Third Quarter 2024 Financial Results | Press release | +1.08% | -1.14% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.49% | -3.67% | |
| RAPT Therapeutics Reports Second Quarter 2024 Financial Results | Press release | -4.49% | -3.67% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.38% | -11.24% | |
| RAPT Therapeutics Reports First Quarter 2024 Financial Results | Press release | +0.38% | -11.24% | |
| Form 10-K RAPT Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.96% | +0.87% | |
| Form 10-Q RAPT Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.96% | +3.15% | |
| RAPT Therapeutics Reports Third Quarter 2023 Financial Results | Press release | -1.96% | +3.15% |
Keep exploring
More RAPT: analyst actions → · SEC filings → · RAPT overview →